Consequently, the high-molecular-weight/total adiponectin ratio is deemed more informative than total adiponectin alone for assessing the risk of conditions like obesity, insulin resistance, T2DM, MetS, and CVDs [65-67]. This evidence concerns the gene ADIPOQ and metabolic syndrome.